These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 4031878)
1. [3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. Schweri MM; Skolnick P; Rafferty MF; Rice KC; Janowsky AJ; Paul SM J Neurochem; 1985 Oct; 45(4):1062-70. PubMed ID: 4031878 [TBL] [Abstract][Full Text] [Related]
2. The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake. Janowsky A; Schweri MM; Berger P; Long R; Skolnick P; Paul SM Eur J Pharmacol; 1985 Jan; 108(2):187-91. PubMed ID: 3920060 [TBL] [Abstract][Full Text] [Related]
3. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex. Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686 [TBL] [Abstract][Full Text] [Related]
4. N-ethylmaleimide irreversibly inhibits the binding of [3H]threo-(+-)-methylphenidate to the stimulant recognition site. Schweri MM Neuropharmacology; 1990 Oct; 29(10):901-8. PubMed ID: 2255384 [TBL] [Abstract][Full Text] [Related]
6. Mercuric chloride and p-chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [3H]methylphenidate to the dopamine transporter. Schweri MM Synapse; 1994 Mar; 16(3):188-94. PubMed ID: 8197581 [TBL] [Abstract][Full Text] [Related]
7. Metaphit inhibits dopamine transport and binding of [3H]methylphenidate, a proposed marker for the dopamine transport complex. Schweri MM; Jacobson AE; Lessor RA; Rice KC Life Sci; 1989; 45(18):1689-98. PubMed ID: 2586226 [TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes. Dubocovich ML; Zahniser NR Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318 [TBL] [Abstract][Full Text] [Related]
9. High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter. Calligaro DO; Eldefrawi ME Membr Biochem; 1987-1988; 7(2):87-106. PubMed ID: 3454391 [TBL] [Abstract][Full Text] [Related]
10. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Bonnet JJ; Protais P; Chagraoui A; Costentin J Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. Andersen PH J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763 [TBL] [Abstract][Full Text] [Related]
12. Binding of bromine-substituted analogs of methylphenidate to monoamine transporters. Pan D; Gatley SJ; Dewey SL; Chen R; Alexoff DA; Ding YS; Fowler JS Eur J Pharmacol; 1994 Oct; 264(2):177-82. PubMed ID: 7851480 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of [3H]hemicholinium-3 binding to rat striatal membranes: evidence for negative cooperative site-site interactions. Chatterjee TK; Cannon JG; Bhatnagar RK J Neurochem; 1987 Oct; 49(4):1191-201. PubMed ID: 3625204 [TBL] [Abstract][Full Text] [Related]
14. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Javitch JA; Blaustein RO; Snyder SH Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116 [TBL] [Abstract][Full Text] [Related]
15. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783. Vaugeois JM; Bonnet JJ; Costentin J Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989 [TBL] [Abstract][Full Text] [Related]
16. Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Schoemaker H; Pimoule C; Arbilla S; Scatton B; Javoy-Agid F; Langer SZ Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):227-35. PubMed ID: 3927176 [TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935. Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the enantiomers of threo-methylphenidate. Patrick KS; Caldwell RW; Ferris RM; Breese GR J Pharmacol Exp Ther; 1987 Apr; 241(1):152-8. PubMed ID: 3572779 [TBL] [Abstract][Full Text] [Related]
19. Fourphit: a selective probe for the methylphenidate binding site on the dopamine transporter. Schweri MM; Thurkauf A; Mattson MV; Rice KC J Pharmacol Exp Ther; 1992 Jun; 261(3):936-42. PubMed ID: 1602399 [TBL] [Abstract][Full Text] [Related]
20. Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine. Gatley SJ; Ding YS; Volkow ND; Chen R; Sugano Y; Fowler JS Eur J Pharmacol; 1995 Aug; 281(2):141-9. PubMed ID: 7589201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]